Press releases, Reports & Disclosures for Gulf Medical Projects Company

Resolution No. (295) of 2024 temporarily suspends trading on the shares of Gulf Medical Projects Company. This is due to the company's AGM being held at 12:00 on 7-Mar-2024, which coincides with the trading session at ADX. The suspension will last from 09:00 on 7-Mar-2024 until ADX receives the AGM results. All heads of departments in ADX are required to execute this resolution in their respective fields. The resolution will be circulated to SCA, the concerned company, all departments at ADX, and all brokers accredited by ADX. The resolution was issued on 15/02/2024.

The Gulf Medical Projects Company (P.S.C.) has submitted its sustainability report for the year 2023.

The Gulf Medical Projects Company, a public shareholding entity, has released its reports and consolidated financial statements for the year ending on 31st December 2023.

The Board of Directors of Gulf Medical Projects Company (PJSC) has invited its shareholders to attend the annual General Assembly meeting on 7th March 2024, either in person or remotely. The meeting will discuss and vote on several agenda items, including the approval of the Board of Directors’ report, the Auditor’s report, the Company’s balance sheet, and profit and loss account for the fiscal year ended on 31st December 2023. Other items include the consideration of a cash dividend recommendation, a proposal on Board remuneration, and the appointment of External auditors for 2024. Shareholders can delegate a non-board member to represent them, and corporate shareholders can delegate a representative. Remote attendees must register to vote electronically. The meeting will only be valid if attended by shareholders who hold or represent by proxy at least 50% of the Company's share capital.

The text provided is not in a recognizable language or format, therefore it cannot be summarized.

Resolution No. 278 of 2024 temporarily suspends trading of Gulf Medical Projects Company shares on ADX. The decision is subject to article No. 16 of the Regulations Concerning the Listing of Securities on ADX. The suspension is due to a board of directors meeting scheduled for 14:00 on 13-Feb-2024, which coincides with the trading session. Trading will be suspended from 09:00 on 13-Feb-2024 until the meeting results are received by ADX. All department heads in ADX are instructed to enforce this resolution in their respective fields. The resolution will be circulated to SCA, the concerned company, all ADX departments, and all brokers accredited by ADX. The resolution was issued on 05/02/2024.